Liraglutide

Sort by

Asn(11)-Linear Liraglutide

  • CAT NUMBER DCTI-D-304
  • CAS NUMBER NA
  • MOLECULAR FORMULA C152H229N43O47
  • MOLECULAR WEIGHT 3410.76

Asn(12)-Linear Liraglutide

  • CAT NUMBER DCTI-D-303
  • CAS NUMBER NA
  • MOLECULAR FORMULA C152H229N43O47
  • MOLECULAR WEIGHT 3410.76

Asn(8)-Linear Liraglutide

  • CAT NUMBER DCTI-D-305
  • CAS NUMBER NA
  • MOLECULAR FORMULA C152H229N43O47
  • MOLECULAR WEIGHT 3410.76

Beta-Asp Linear Liraglutide-1

  • CAT NUMBER DCTI-D-376
  • CAS NUMBER NA
  • MOLECULAR FORMULA C151H228N42O47
  • MOLECULAR WEIGHT 3383.73

Cyclic-His-Liraglutide

  • CAT NUMBER DCTI-D-378
  • CAS NUMBER NA
  • MOLECULAR FORMULA C173H265N43O51
  • MOLECULAR WEIGHT 3763.27

D-Allo-Thr(11)-Liraglutide

  • CAT NUMBER DCTI-D-206
  • CAS NUMBER NA
  • MOLECULAR FORMULA C172H265N43O51
  • MOLECULAR WEIGHT 3751.56

D-Allo-Thr(13)-Liraglutide

  • CAT NUMBER DCTI-D-199
  • CAS NUMBER NA
  • MOLECULAR FORMULA C172H265N43O51
  • MOLECULAR WEIGHT 3751.56

D-Arg(28)-Liraglutide

  • CAT NUMBER DCTI-D-151
  • CAS NUMBER NA
  • MOLECULAR FORMULA C172H265N43O51
  • MOLECULAR WEIGHT 3751.26

D-Gln(17)-Liraglutide

  • CAT NUMBER DCTI-D-401
  • CAS NUMBER NA
  • MOLECULAR FORMULA C172H265N43O51
  • MOLECULAR WEIGHT 3751.26
LOAD MORE
You're viewed 18 of 50 products
References
FAQ's

Frequently Asked Questions

Liraglutide impurities can be identified using analytical methods such as high-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), etc.

Liraglutide impurities can be purified after synthesis using various techniques such as preparative HPLC, flash chromatography, or crystallization. These methods involve separating the impurities from the main product based on their chemical properties and physical characteristics.

Liraglutide impurities should be stored at recommended temperature conditions, typically 2-8°C or -20°C, depending on their stability. Improper storage can lead to degradation and loss of purity, so it's important to follow the manufacturer's instructions.

Liraglutide impurities can affect drug efficacy and safety. It is observed that impurities can cause adverse effects such as allergic reactions, injection site reactions, gastrointestinal disturbances, pancreatitis, or liver damage due to their toxicity or carcinogenic nature. Identifying and quantifying the impurities is essential during drug development.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart